Loading...
•
Aug 31, 2020
AngioDynamics Q1 2021 Earnings Report
AngioDynamics reported a net sales increase of 6.3% compared to the prior-year quarter, with a GAAP loss per share of $0.11 and adjusted earnings per share of $0.02.
Key Takeaways
AngioDynamics reported a strong first quarter with net sales of $70.2 million, a 6.3% increase compared to the prior-year quarter. The company's gross margin was 50.9%, and they reported a GAAP loss per share of $0.11 and adjusted earnings per share of $0.02. They expect fiscal year 2021 net sales between $278 and $284 million and fiscal year 2021 adjusted earnings per share between $0.00 and $0.05.
Net sales increased by 6.3% to $70.2 million compared to the prior-year quarter, including a $5.2 million order from the UK's National Health Service (NHS).
Gross margin decreased to 50.9%, a decline of 700 basis points year over year.
GAAP loss per share was $0.11, while adjusted earnings per share were $0.02.
Cash and cash equivalents were $47.9 million as of August 31, 2020, compared to $54.4 million on May 31, 2020.
Revenue by Geographic Location
Forward Guidance
The Company expects fiscal year 2021 net sales to be in the range of $278 to $284 million and fiscal year 2021 adjusted earnings per share to be in the range of $0.00 to $0.05.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...